GI-11 IIT: A Phase 1/1b Trial of AB801 in Combination with Chemotherapy and PD-1/PD-L1 Blockade in Patients with Cholangiocarcinoma or Pancreatic Adenocarcinoma

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

• If you need assistance with ClinicalTrials.gov registration for an oncology study, please contact the Jonsson Comprehensive Cancer Center's Office of Regulatory Compliance.
• If you need assistance with ClinicalTrials.gov registration for a non-oncology study, please contact the Office of Regulatory Affairs.